Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed Event

Biophytis  announces its participation at the 41st JP Morgan Healthcare Conference, which will be held in San Francisco from the 9th to 12th of January 2023, and at the Invest Securities Biomed Event which will be held on the 24th of January 2023 in Paris.

The JP Morgan Healthcare Conference is the world’s largest healthcare investment event, connecting the world’s leading healthcare companies, biotechs and technology innovators with members of the international financial community.

Invest Securities’ Biomed Event is the annual forum dedicated to the healthcare sector that brings together biotech or medtech companies, pharmaceutical companies and institutional investors in a one-to-one format.
Both events will be an opportunity for Biophytis to meet with both American and European investors and discuss the status of its clinical trials, including the latest results of the COVA clinical trial in Covid-19.